Table 1.

Expression of Resistance Proteins in Childhood ALL, AML, and Normal Cells

P-gp MRPLRP
C219 MRK16 MRPm6 MRPr1 LRP56
ALL  
 Initial  2.06 (1.63-2.60)  3.36 (2.51-4.38) 2.26 (1.98-2.62)  2.87 (2.49-3.35)  1.99 (1.64-2.34) 
 Relapse  2.32 (1.51-2.86)  3.01 (2.38-3.74) 2.25 (1.83-2.70)  2.96 (2.64-3.44)  2.30 (1.76-3.01) 
AML  
 Initial  2.09 (1.38-2.66)  2.01 (1.76-2.59) 1.94 (1.68-2.18)  2.32 (1.50-2.89)  3.91 (2.86-7.39) 
 Relapse  1.76 (1.67-2.46)  2.28 (2.10-2.64) 2.23 (1.86-2.46)  2.85 (1.64-3.31)  2.49 (2.09-2.92) 
Normal cells  
 PB lymphocytes  1.88 (1.49-2.01) 3.24 (2.74-4.06)  1.88 (1.55-2.02)  2.70 (2.18-2.99) 5.14 (4.25-7.22)  
 BM-150 1.52/1.82 1.57/2.87/3.31  NT  1.27/1.35/1.93  1.86/2.33/2.37 
P-gp MRPLRP
C219 MRK16 MRPm6 MRPr1 LRP56
ALL  
 Initial  2.06 (1.63-2.60)  3.36 (2.51-4.38) 2.26 (1.98-2.62)  2.87 (2.49-3.35)  1.99 (1.64-2.34) 
 Relapse  2.32 (1.51-2.86)  3.01 (2.38-3.74) 2.25 (1.83-2.70)  2.96 (2.64-3.44)  2.30 (1.76-3.01) 
AML  
 Initial  2.09 (1.38-2.66)  2.01 (1.76-2.59) 1.94 (1.68-2.18)  2.32 (1.50-2.89)  3.91 (2.86-7.39) 
 Relapse  1.76 (1.67-2.46)  2.28 (2.10-2.64) 2.23 (1.86-2.46)  2.85 (1.64-3.31)  2.49 (2.09-2.92) 
Normal cells  
 PB lymphocytes  1.88 (1.49-2.01) 3.24 (2.74-4.06)  1.88 (1.55-2.02)  2.70 (2.18-2.99) 5.14 (4.25-7.22)  
 BM-150 1.52/1.82 1.57/2.87/3.31  NT  1.27/1.35/1.93  1.86/2.33/2.37 

Values represent the median FI and the 25th and 75th percentiles (in parentheses), which are based on 101 to 112 initial ALL, 23 to 29 relapsed ALL, 13 to 20 initial AML, 5 to 7 relapsed AML, and 8 to 14 normal PB samples. Initial versus relapsed AML: LRP56, P = .041. Initial ALL versus initial AML: MRK16, P < .001; MRPm6,P = .007; MRPr1, P = .01; LRP56, P < .001. Initial ALL versus normal PB lymphocytes: MRPm6, P = .008; LRP56, P < .001.

Abbreviation: NT, not tested.

F0-150

The FI of 2 to 3 normal BM samples are listed.

Close Modal

or Create an Account

Close Modal
Close Modal